AKAO News and Press, Achaogen From 02/15/19

Achaogen (NASDAQ: AKAO )  -37%  on pricing stock and warrant offering. More news on: Achaogen, Marin Software, TrueCar, Inc, Stocks on the move, Read more ...

Achaogen (NASDAQ: AKAO ) prices its public offering of 15M shares of common stock and short-term warrants to purchase up to 15M common shares and long-term warrants at a price $1.00 per share/warrant, for gross proceeds of $15M. More news on: Achaogen, Healthcare stocks news, Stocks on t...

SOUTH SAN FRANCISCO, Calif., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today announced the pricing of...

Achaogen (NASDAQ: AKAO ) has slid 23.9% on heavy after-hours volume after proposing a public offering of its common stock. More news on: Achaogen, Healthcare stocks news, Stocks on the move, Read more ...

SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, today announced that it has c...

On June 26, 2019, Achaogen (AKAO) announced mixed news to its anxious investors - the company's lead drug candidate, the antibiotic Zemdri (plazomicin), had been approved for the treatment of complicated urinary tract infections (cUTI), but had received a CRL for its potential indication for...

-- Company provides update on ZEMDRI ®  commercialization and launch --  -- Data from both the EPIC and CARE Phase 3 clinical studies of plazomicin are expected in peer-reviewed publication -- SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Achaog...

-- Plazomicin may be well-suited to play a critical role in biodefense preparedness -- SOUTH SAN FRANCISCO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial age...

Gainers:  Fortress Biotech (NASDAQ: FBIO ) +41% . MeiraGTx Holdings (NASDAQ: MGTX ) +29% . Eldorado Gold (NYSE: EGO ) +23% . Avon Products (NYSE: AVP ) +22% . Silicom (NASDAQ: SILC ) +20% . Onconova Therapeutics (NASDAQ: ONTX ) +20% . 1-800-FLOWERS.COM (NASDAQ: FLWS ) +19% . Tu...

Gainers: Organogenesis Holdings ( ORGO ) +57% . Rand Capital (NASDAQ: RAND ) +32% . PHI (NASDAQ: PHII ) +26% . ClearOne (NASDAQ: CLRO ) +23% . Bristow Group (NYSE: BRS ) +20% . Digital Ally (NASDAQ: DGLY ) +17% . SITO Mobile (NASDAQ: SITO ) +16% . Achaogen (NASDAQ: AKAO ) +16% . C...